Bank Of Montreal Regeneron Pharmaceuticals, Inc. Transaction History

Bank Of Montreal

$202 Billion
Q4 2024

A detailed history of Bank Of Montreal transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 153,267 shares of REGN stock, worth $103 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

153,267

Previous 188,157 18.54%

Holding current value

$103 Million

Previous $198 Million 44.8%

% of portfolio

0.05%

Previous 0.09%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$701.85 - $1046.91 $24.5 Million - $36.5 Million	-34,890 Reduced 18.54%	153,267 $109 Million
Q3 2024 Nov 13, 2024	BUY	$1024.09 - $1201.76 $2.94 Million - $3.44 Million	2,866 Added 1.55%	188,157 $198 Million
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $38.7 Million - $46.9 Million	-43,762 Reduced 19.11%	185,291 $195 Million
Q1 2024 May 13, 2024	SELL	$902.69 - $993.35 $50.7 Million - $55.7 Million	-56,112 Reduced 19.68%	229,053 $220 Million
Q4 2023 Feb 08, 2024	BUY	$775.18 - $881.7 $80.7 Million - $91.7 Million	104,050 Added 57.45%	285,165 $250 Million
Q3 2023 Nov 01, 2023	BUY	$692.45 - $844.37 $23.1 Million - $28.1 Million	33,317 Added 22.54%	181,115 $149 Million
Q2 2023 Aug 02, 2023	BUY	$700.03 - $830.35 $26.4 Million - $31.3 Million	37,695 Added 34.24%	147,798 $106 Million
Q1 2023 Jun 13, 2024	SELL	$680.49 - $826.97 $97.1 Million - $118 Million	-142,764 Reduced 62.33%	86,289 $70.9 Million
Q4 2022 Feb 01, 2023	BUY	$705.89 - $766.39 $27.5 Million - $29.8 Million	38,901 Added 54.63%	110,103 $79.4 Million
Q3 2022 Nov 10, 2022	SELL	$573.97 - $724.32 $31.9 Million - $40.2 Million	-55,551 Reduced 43.83%	71,202 $49.8 Million
Q2 2022 Aug 11, 2022	BUY	$548.35 - $738.84 $21.2 Million - $28.6 Million	38,662 Added 43.89%	126,753 $76.4 Million
Q1 2022 May 12, 2022	SELL	$595.12 - $698.43 $21.1 Million - $24.7 Million	-35,419 Reduced 28.68%	88,091 $61.3 Million
Q4 2021 Feb 11, 2022	SELL	$543.48 - $670.97 $19.4 Million - $24 Million	-35,725 Reduced 22.44%	123,510 $80.3 Million
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $17.9 Million - $21.3 Million	31,248 Added 24.41%	159,235 $97.2 Million
Q2 2021 Aug 12, 2021	BUY	$472.8 - $558.54 $60.5 Million - $71.5 Million	127,987 New	127,987 $70 Million

Others Institutions Holding REGN

# of Institutions

1,487

Shares Held

83.4M

Call Options Held

1.32M

Put Options Held

1.52M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account